{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:16:48Z","timestamp":1786267008862,"version":"build-2736575974"},"reference-count":108,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tips.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T14:19:05Z","timestamp":1760797145000},"page":"1105-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting SARM1: from inhibition for neuroprotection to activation for neuroablation"],"prefix":"10.1016","volume":"46","author":[{"given":"Peter","family":"Arthur-Farraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-6436","authenticated-orcid":false,"given":"Andrea","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2025.09.003_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2025.09.003_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tips.2020.01.006","article-title":"Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration","volume":"41","author":"Krauss","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2025.09.003_bb0015","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/s41433-024-03025-0","article-title":"Programmed axon death: a promising target for treating retinal and optic nerve disorders","volume":"38","author":"Loreto","year":"2024","journal-title":"EYE"},{"key":"10.1016\/j.tips.2025.09.003_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09411-2","article-title":"Axonal injury is a targetable driver of glioblastoma progression","author":"Clements","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.09.003_bb0025","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.neuron.2022.08.017","article-title":"Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease","volume":"110","author":"Bratkowski","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.09.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208457119","article-title":"Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain","volume":"119","author":"Feldman","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.09.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108588","article-title":"Small molecule SARM1 inhibitors recapitulate the SARM1\u2212\/\u2212 phenotype and allow recovery of a metastable pool of axons fated to degenerate","volume":"34","author":"Hughes","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110108","article-title":"Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration","volume":"37","author":"Gould","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1084\/jem.20181040","article-title":"Gene therapy targeting SARM1 blocks pathological axon degeneration in mice","volume":"216","author":"Geisler","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2025.09.003_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtn.2023.02.029","article-title":"Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies","volume":"32","author":"Liu","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tips.2025.09.003_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00511-x","article-title":"Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients","volume":"17","author":"Bloom","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2025.09.003_bb0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70905","article-title":"Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders","volume":"10","author":"Gilley","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72823","article-title":"Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1","volume":"10","author":"Loreto","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2024.102884","article-title":"Augustus Waller\u2019s foresight realized: SARM1 in peripheral neuropathies","volume":"87","author":"Geisler","year":"2024","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tips.2025.09.003_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106986","article-title":"SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides","volume":"213","author":"Loreto","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2025.09.003_bb0080","article-title":"Stepwise activation of SARM1 for cell death and axon degeneration revealed by a biosynthetic NMN mimic","volume":"122","author":"Huang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2025.09.003_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44386-025-00016-3","article-title":"SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses","volume":"2","author":"Mani","year":"2025","journal-title":"NPJ Drug Discov."},{"key":"10.1016\/j.tips.2025.09.003_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44386-025-00023-4","article-title":"Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration","volume":"2","author":"Leahey","year":"2025","journal-title":"NPJ Drug Discov."},{"key":"10.1016\/j.tips.2025.09.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-025-02009-9","article-title":"SARM1 activation promotes axonal degeneration via a two-step phase transition","author":"Zhang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109872","article-title":"Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss","volume":"37","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1158388","article-title":"SARM1 detection in myelinating glia: sarm1\/Sarm1 is dispensable for PNS and CNS myelination in zebrafish and mice","volume":"17","author":"Fazal","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2025.09.003_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000004228","article-title":"The multispecialty toxin: a literature review of botulinum toxin","volume":"10","author":"Bach","year":"2022","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"10.1016\/j.tips.2025.09.003_bb0115","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","article-title":"Sarm1-mediated axon degeneration requires both SAM and TIR interactions","volume":"33","author":"Gerdts","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2025.09.003_bb0120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death Pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.09.003_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s42003-020-0776-9","article-title":"Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration","volume":"3","author":"Tian","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0130","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s13311-021-01125-3","article-title":"Lessons from injury: how nerve injury studies reveal basic biological mechanisms and therapeutic opportunities for peripheral nerve diseases","volume":"18","author":"Arthur-Farraj","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2025.09.003_bb0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD+ ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.09.003_bb0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.isci.2019.05.001","article-title":"A cell-permeant mimetic of NMN activates SARM1 to produce cyclic ADP-ribose and induce non-apoptotic cell death","volume":"15","author":"Zhao","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.tips.2025.09.003_bb0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tins.2021.10.014","article-title":"Mitochondrial dysfunction as a trigger of programmed axon death","volume":"45","author":"Merlini","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2025.09.003_bb0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/cdd.2014.164","article-title":"A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration","volume":"22","author":"Di Stefano","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tips.2025.09.003_bb0155","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.celrep.2015.11.032","article-title":"Wallerian degeneration is executed by an NMN-SARM1-dependent late Ca2+ influx but only modestly influenced by mitochondria","volume":"13","author":"Loreto","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neures.2023.01.004","article-title":"NMN: the NAD precursor at the intersection between axon degeneration and anti-ageing therapies","volume":"197","author":"Loreto","year":"2023","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.tips.2025.09.003_bb0165","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cub.2017.01.070","article-title":"NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo","volume":"27","author":"Di Stefano","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0170","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2015.02.060","article-title":"Absence of SARM1 rescues development and survival of NMNAT2-deficient axons","volume":"10","author":"Gilley","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19749","article-title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion","volume":"5","author":"Sasaki","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103812","article-title":"SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated by multiple physiologically relevant NAD metabolites","volume":"25","author":"Angeletti","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.tips.2025.09.003_bb0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41586-020-2862-z","article-title":"The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1","volume":"588","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tips.2025.09.003_bb0195","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62027","article-title":"SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration","volume":"9","author":"Sasaki","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0200","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 Toll\/Interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2025.09.003_bb0205","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD+ destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.tips.2025.09.003_bb0210","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2025.09.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105630","article-title":"SARM1 is responsible for calpain-dependent dendrite degeneration in mouse hippocampal neurons","volume":"300","author":"Miyamoto","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2025.09.003_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78896-w","article-title":"Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation","volume":"10","author":"Cetinkaya-Fisgin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0225","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71148","article-title":"Live imaging reveals the cellular events downstream of SARM1 activation","volume":"10","author":"Ko","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80245","article-title":"The NAD+ precursor NMN activates dSarm to trigger axon degeneration in Drosophila","volume":"11","author":"Llobet Rosell","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113636","article-title":"SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration","volume":"339","author":"Chen","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0240","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s13311-022-01297-6","article-title":"Axon biology in ALS: mechanisms of axon degeneration and prospects for therapy","volume":"19","author":"Coleman","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.tips.2025.09.003_bb0245","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ng.2370","article-title":"Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis","volume":"44","author":"Chiang","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2025.09.003_bb0250","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2361","article-title":"NMNAT1 mutations cause Leber congenital amaurosis","volume":"44","author":"Falk","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2025.09.003_bb0255","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ng.2356","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration","volume":"44","author":"Koenekoop","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2025.09.003_bb0260","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ng.2357","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy","volume":"44","author":"Perrault","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2025.09.003_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112958","article-title":"Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia","volume":"320","author":"Huppke","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112961","article-title":"Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence","volume":"320","author":"Lukacs","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159800","article-title":"Macrophage depletion blocks congenital SARM1-dependent neuropathy","volume":"132","author":"Dingwall","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2025.09.003_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113219","article-title":"Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models","volume":"327","author":"Harlan","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0285","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/hmg\/ddt587","article-title":"A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis","volume":"23","author":"Fogh","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2025.09.003_bb0290","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng.3622","article-title":"Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis","volume":"48","author":"van Rheenen","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2025.09.003_bb0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198001103020202","article-title":"The neurotoxicity of the rat poison vacor. A clinical study of 12 cases","volume":"302","author":"LeWitt","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2025.09.003_bb0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2018.01.012","article-title":"Identification of the nicotinamide salvage pathway as a new toxification route for antimetabolites","volume":"25","author":"Buonvicino","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0305","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.2147\/DDDT.S329547","article-title":"The expanding role of pyridine and dihydropyridine scaffolds in drug design","volume":"15","author":"Ling","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.tips.2025.09.003_bb0310","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2017.09.027","article-title":"Sarm1 deletion, but not WldS, confers lifelong rescue in a mouse model of severe axonopathy","volume":"21","author":"Gilley","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0315","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.7150\/thno.49054","article-title":"SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-\u03baB signaling","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.tips.2025.09.003_bb0320","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","article-title":"Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules","volume":"82","author":"Shi","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2025.09.003_bb0325","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/brain\/awab184","article-title":"Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy","volume":"144","author":"Bosanac","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.tips.2025.09.003_bb0330","article-title":"Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate","volume":"10","author":"Li","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00018-022-04641-3","article-title":"A duplex structure of SARM1 octamers stabilized by a new inhibitor","volume":"80","author":"Khazma","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2025.09.003_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113842","article-title":"Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection","volume":"345","author":"Sasaki","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0345","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/neuros\/nyaa527","article-title":"Congress of neurological surgeons systematic review and evidence-based guideline on neuroablative procedures for patients with cancer pain","volume":"88","author":"Raslan","year":"2021","journal-title":"Neurosurgery"},{"key":"10.1016\/j.tips.2025.09.003_bb0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/practneurol-2011-000155","article-title":"Spasticity: pathophysiology, evaluation and management","volume":"12","author":"Kheder","year":"2012","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0355","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2010.149","article-title":"Use of botulinum toxin in the neurology clinic","volume":"6","author":"Lim","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40265-015-0520-9","article-title":"Capsaicin 8 % patch: a review in peripheral neuropathic pain","volume":"76","author":"Burness","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.tips.2025.09.003_bb0365","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mdc3.13181","article-title":"Management of secondary poor response to botulinum toxin in cervical dystonia: a multicenter audit","volume":"8","author":"Tucker","year":"2021","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.tips.2025.09.003_bb0370","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cot\u00e9","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tips.2025.09.003_bb0375","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41419-022-05202-z","article-title":"Astrocytic SARM1 promotes neuroinflammation and axonal demyelination in experimental autoimmune encephalomyelitis through inhibiting GDNF signaling","volume":"13","author":"Jin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2025.09.003_bb0380","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-024-01736-9","article-title":"Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma","volume":"12","author":"Zeng","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tips.2025.09.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.261557","article-title":"Schwann cells are axo-protective after injury irrespective of myelination status in mouse Schwann cell-neuron cocultures","volume":"136","author":"Mutschler","year":"2023","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tips.2025.09.003_bb0390","unstructured":"Arthur-Farraj, P. and Loreto, A. Cambridge Enterprise Ltd. SARM1 agents for use in therapy and cosmetics. WO 2024100421"},{"key":"10.1016\/j.tips.2025.09.003_bb0395","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.celrep.2020.03.062","article-title":"Passenger mutations confound phenotypes of SARM1-deficient mice","volume":"31","author":"Uccellini","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105620","article-title":"SARM1 regulates NAD+-linked metabolism and select immune genes in macrophages","volume":"300","author":"Shanahan","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2025.09.003_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109940","article-title":"SARM1 regulates pro-inflammatory cytokine expression in human monocytes by NADase-dependent and -independent mechanisms","volume":"27","author":"Sugisawa","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.tips.2025.09.003_bb0410","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.201008050","article-title":"Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology","volume":"193","author":"Chen","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0415","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbi.2013.12.002","article-title":"Sarm1, a neuronal inflammatory regulator, controls social interaction, associative memory and cognitive flexibility in mice","volume":"37","author":"Lin","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tips.2025.09.003_bb0420","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41419-022-05083-2","article-title":"SARM1 deletion in parvalbumin neurons is associated with autism-like behaviors in mice","volume":"13","author":"Xiang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2025.09.003_bb0425","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12974-025-03423-5","article-title":"Targeting SARM1 as a novel neuroprotective therapy in neurotropic viral infections","volume":"22","author":"He","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2025.09.003_bb0430","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13071-025-06721-2","article-title":"SARM regulates cell apoptosis and inflammation during Toxoplasma gondii infection through a multistep mechanism","volume":"18","author":"Gao","year":"2025","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.tips.2025.09.003_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.860410","article-title":"SARM1 depletion slows axon degeneration in a CNS model of neurotropic viral infection","volume":"15","author":"Crawford","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tips.2025.09.003_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008343","article-title":"Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies","volume":"16","author":"Sundaramoorthy","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tips.2025.09.003_bb0445","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13238-021-00835-w","article-title":"Sarm1-mediated neurodegeneration within the enteric nervous system protects against local inflammation of the colon","volume":"12","author":"Sun","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.tips.2025.09.003_bb0450","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/neu.480230507","article-title":"Consequences of slow wallerian degeneration for regenerating motor and sensory axons","volume":"23","author":"Brown","year":"1992","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.tips.2025.09.003_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp9155","article-title":"Deletion of murine Sarm1 results in a microenvironment that delays peripheral nerve regeneration after injury","volume":"17","author":"Schmitd","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2025.09.003_bb0460","article-title":"In vivo morphological dynamics of single laser-axotomized corneal nerve fibers in Sarm1-null adult mice","author":"I\u00f1igo-Portugu\u00e9s","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.tips.2025.09.003_bb0465","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1753425913485877","article-title":"Neuronally-expressed Sarm1 regulates expression of inflammatory and antiviral cytokines in brains","volume":"20","author":"Lin","year":"2014","journal-title":"Innate Immun."},{"key":"10.1016\/j.tips.2025.09.003_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113040","article-title":"Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury","volume":"321","author":"Marion","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002472","article-title":"NMNAT2:HSP90 complex mediates proteostasis in proteinopathies","volume":"14","author":"Ali","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2025.09.003_bb0480","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.celrep.2013.04.013","article-title":"The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction","volume":"3","author":"Babetto","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0485","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s12035-019-01796-2","article-title":"DLK activation synergizes with mitochondrial dysfunction to downregulate axon survival factors and promote SARM1-dependent axon degeneration","volume":"57","author":"Summers","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2025.09.003_bb0490","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2016.09.043","article-title":"An atypical SCF-like ubiquitin ligase complex promotes Wallerian degeneration through regulation of axonal Nmnat2","volume":"17","author":"Yamagishi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2025.09.003_bb0495","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22540","article-title":"MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2","volume":"6","author":"Walker","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.tips.2025.09.003_bb0500","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129920","article-title":"Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program","volume":"4","author":"Geisler","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.tips.2025.09.003_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104678","article-title":"Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration","volume":"134","author":"Loreto","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2025.09.003_bb0510","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161566","article-title":"A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model","volume":"132","author":"Sato-Yamada","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2025.09.003_bb0515","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1523\/JNEUROSCI.18-21-08947.1998","article-title":"Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: correlation with sensory function","volume":"18","author":"Simone","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2025.09.003_bb0520","first-page":"167","article-title":"Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins","volume":"84","author":"Thesleff","year":"1990","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2025.09.003_bb0525","first-page":"469","article-title":"Ultrastructural analysis of mouse levator auris longus muscle intoxicated in vivo by botulinum neurotoxin type A","volume":"49","author":"Velasco","year":"2008","journal-title":"Investig. Clin."},{"key":"10.1016\/j.tips.2025.09.003_bb0530","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1113\/jphysiol.1981.sp013787","article-title":"The neuromuscular junction of the mouse after black widow spider venom","volume":"316","author":"Duchen","year":"1981","journal-title":"J. Physiol."},{"key":"10.1016\/j.tips.2025.09.003_bb0535","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/exnr.1999.7275","article-title":"The neurotoxicity of the venom phospholipases A(2), notexin and taipoxin","volume":"161","author":"Harris","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tips.2025.09.003_bb0540","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jnc.13956","article-title":"Animal models for studying motor axon terminal paralysis and recovery","volume":"142","author":"Rigoni","year":"2017","journal-title":"J. Neurochem."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725002196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614725002196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:41:17Z","timestamp":1762674077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614725002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0165614725002196"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2025.09.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SARM1: from inhibition for neuroprotection to activation for neuroablation","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}